[1]
Badabagni, P., Ramadevi, B. and Sambangi, J. 2021. Efficacy and safety of adalimumab in treating patients with moderate to severe plaque psoriasis: a retrospective study. International Journal of Research in Dermatology. 8, 1 (Dec. 2021), 8–14. DOI:https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20214443.